stockrowNeoGenomics, Inc. (NEO) vs OPKO Health, Inc. (OPK)
- NeoGenomics, Inc. NEO 16.89 +2.43%
- OPKO Health, Inc. OPK 1.74 −0.57%
NeoGenomics, Inc. and OPKO Health, Inc. are both Diagnostics & Research companies. NeoGenomics, Inc. is the larger, with a market value of $2.1B against $1.3B — 1.6× the size. NeoGenomics, Inc. grew revenue faster over the last twelve months: 11.1% against 9.16%. NeoGenomics, Inc. has the higher net margin (−4.10% vs −24.8%) and the lower return on invested capital (−2.97% vs −2.42%). Across the 19 metrics below, NeoGenomics, Inc. leads on 12 and OPKO Health, Inc. on 7.
Valuation
Profitability
| Metric | NEO | OPK | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 44.77% | 41.33% | 48.32% |
| Operating margin | (6.27%) | (7.72%) | (5.68%) |
| Net margin | (4.10%) | (24.80%) | (4.10%) |
| Free cash flow margin | (3.37%) | (49.37%) | 0.00% |
| Return on equity | (3.94%) | (12.23%) | 0.00% |
| Return on assets | (2.35%) | (7.64%) | (6.05%) |
| Return on invested capital | (2.97%) | (2.42%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack